These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28682883)

  • 1. Nivolumab-induced myasthenia gravis in a patient with squamous cell lung carcinoma: Case report.
    Chen YH; Liu FC; Hsu CH; Chian CF
    Medicine (Baltimore); 2017 Jul; 96(27):e7350. PubMed ID: 28682883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexisting myasthenia gravis, myositis, and polyneuropathy induced by ipilimumab and nivolumab in a patient with non-small-cell lung cancer: A case report and literature review.
    Chen JH; Lee KY; Hu CJ; Chung CC
    Medicine (Baltimore); 2017 Dec; 96(50):e9262. PubMed ID: 29390370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature.
    Veccia A; Kinspergher S; Grego E; Peterlana D; Berti A; Tranquillini E; Caffo O
    Anticancer Drugs; 2020 Jun; 31(5):540-544. PubMed ID: 32011360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of anti-titin antibody positive nivolumab-related necrotizing myopathy with myasthenia gravis].
    Isami A; Uchiyama A; Shimaoka Y; Suzuki S; Kawachi I; Fujita N
    Rinsho Shinkeigaku; 2019 Jul; 59(7):431-435. PubMed ID: 31243249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of myasthenia gravis and myositis induced by nivolumab].
    Konoeda F; Suzuki S; Nishimoto Y; Hoshino H; Takagi M
    Rinsho Shinkeigaku; 2017 Jul; 57(7):373-377. PubMed ID: 28674287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.
    Li H; Ma W; Yoneda KY; Moore EH; Zhang Y; Pu LL; Frampton GM; Molmen M; Stephens PJ; Li T
    J Hematol Oncol; 2017 Feb; 10(1):64. PubMed ID: 28245875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia Gravis After Nivolumab Therapy for Squamous Cell Carcinoma of the Bladder.
    Chang E; Sabichi AL; Sada YH
    J Immunother; 2017 Apr; 40(3):114-116. PubMed ID: 28234667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint-mediated myositis and myasthenia gravis: A case report and review of evaluation and management.
    Kang KH; Grubb W; Sawlani K; Gibson MK; Hoimes CJ; Rogers LR; Lavertu P; Yao M
    Am J Otolaryngol; 2018; 39(5):642-645. PubMed ID: 29903623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis and myopathy after nivolumab treatment for non-small cell lung carcinoma: A case report.
    Kim JS; Nam TS; Kim J; Kho BG; Park CK; Oh IJ; Kim YC
    Thorac Cancer; 2019 Oct; 10(10):2045-2049. PubMed ID: 31436031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsed Myasthenia Gravis after Nivolumab Treatment.
    Mitsune A; Yanagisawa S; Fukuhara T; Miyauchi E; Morita M; Ono M; Tojo Y; Ichinose M
    Intern Med; 2018 Jul; 57(13):1893-1897. PubMed ID: 29434145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis induced by nivolumab in patients with non-small-cell lung cancer: a case report and literature review.
    Hasegawa Y; Kawai S; Ota T; Tsukuda H; Fukuoka M
    Immunotherapy; 2017 Aug; 9(9):701-707. PubMed ID: 28649876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanoma.
    Shirai T; Sano T; Kamijo F; Saito N; Miyake T; Kodaira M; Katoh N; Nishie K; Okuyama R; Uhara H
    Jpn J Clin Oncol; 2016 Jan; 46(1):86-8. PubMed ID: 26491202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An autopsy case of nivolumab-induced myasthenia gravis and myositis].
    Sawai T; Hosokawa T; Shigekiyo T; Ogawa S; Sano E; Arawaka S
    Rinsho Shinkeigaku; 2019 Jun; 59(6):360-364. PubMed ID: 31142711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
    Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
    Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocarditis and myasthenia gravis by combined nivolumab and ipilimumab immunotherapy for renal cell carcinoma: A case report of successful management.
    Yanase T; Moritoki Y; Kondo H; Ueyama D; Akita H; Yasui T
    Urol Case Rep; 2021 Jan; 34():101508. PubMed ID: 33318935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of myasthenia gravis and myositis induced by pembrolizumab].
    Noda T; Kageyama H; Miura M; Tamura T; Ito H
    Rinsho Shinkeigaku; 2019 Aug; 59(8):502-508. PubMed ID: 31341124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myasthenia gravis induced by inmuno checkpoints inhibitors: first case report secondary to avelumab therapy and review of published cases].
    Reyes-Bueno JA; Rodriguez-Santos L; Serrano-Castro PJ
    Rev Neurol; 2019 Apr; 68(8):333-338. PubMed ID: 30963530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis induced by nivolumab therapy in a patient with non-small-cell lung cancer.
    Polat P; Donofrio PD
    Muscle Nerve; 2016 Sep; 54(3):507. PubMed ID: 27121245
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dermatomyositis with squamous cell carcinoma of the lungs secondary to nivolumab treatment: a case report].
    Miyashita K; Kajikawa H; Utsunomiya T; Hosaka M; Naito Y; Tomimoto H
    Rinsho Shinkeigaku; 2020 Nov; 60(11):768-772. PubMed ID: 33115992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA Nephropathy after Nivolumab Therapy for Postoperative Recurrence of Lung Squamous Cell Carcinoma.
    Kishi S; Minato M; Saijo A; Murakami N; Tamaki M; Matsuura M; Murakami T; Nagai K; Abe H; Nishioka Y; Doi T
    Intern Med; 2018 May; 57(9):1259-1263. PubMed ID: 29279511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.